Patents
US 10815485 B2: RNA interference in skin indications
- Granted
- 2020-10-27
- Filed
- 2018-02-26 application 15905118
- Type
- Utility · 5 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications.
Source: PVGPATDIS, file of 2026-04-10 (ipg201027.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Phio Pharmaceuticals Corp. 24 patents | US company or organization | Marlborough, MA | PHIO PHARMACEUTICALS CORP. SEC filer EXACT medium confidence: identical full name, one of each nationally | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Anastasia Khvorova | Westborough, MA | 193 | PVGPATDIS, file of 2026-04-10 | |
| William Salomon | Worcester, MA | 35 | PVGPATDIS, file of 2026-04-10 | |
| Joanne Kamens | Newton, MA | 30 | PVGPATDIS, file of 2026-04-10 | |
| Dmitry Samarsky | Westborough, MA | 30 | PVGPATDIS, file of 2026-04-10 | |
| Tod M. Woolf | Sudbury, MA | 41 | PVGPATDIS, file of 2026-04-10 | |
| Pamela Pavco | Longmont, CO | 14 | PVGPATDIS, file of 2026-04-10 | |
| James Cardia | Franklin, MA | 23 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C12N | Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media | C12N15/1136 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P1/16 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2018-12-07 | Name change Change of name | RXI PHARMACEUTICALS CORPORATION signed 2018-11-14 | PHIO PHARMACEUTICALS CORP. MARLBOROUGH, MA | 48380/9 | PASDL, file of 2026-10-15 |
| 2018-06-11 | Assignment Assignment of assignor's interest | WOOLF, TOD M. signed 2012-07-31 KAMENS, JOANNE signed 2012-08-06 KHVOROVA, ANASTASIA signed 2012-08-07 SALOMON, WILLIAM signed 2012-08-07 PAVCO, PAMELA A. signed 2012-08-30 SAMARSKY, DMITRY signed 2012-09-04 CARDIA, JAMES signed 2013-06-26 | RXI PHARMACEUTICALS CORPORATION MARLBOROUGH, MA | 46331/634 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.